Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Reinvestment Rate of 0.29x as of June 2023, reinvesting €601.56 Million (capex €524.46 Million plus investments €77.10 Million) from operating cash flow of €2.10 Billion. Check Guangzhou Baiyunshan Pharmaceutical Hold cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 12 annual periods. Explore Guangzhou Baiyunshan Pharmaceutical Hold long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For live market cap and broader valuation context, see GU5 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.73x | €5.96 Billion | €3.44 Billion | €1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | €4.74 Billion | €4.10 Billion | €1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | €7.62 Billion | €7.00 Billion | €1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | €1.30 Billion | €5.67 Billion | €1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | €1.39 Billion | €585.19 Million | €876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | €3.63 Billion | €5.02 Billion | €2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | €909.71 Million | €5.22 Billion | €478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | €2.57 Billion | €1.83 Billion | €196.77 Million | ▲ +646.4% |
| 2016 | 0.19x | €477.18 Million | €2.54 Billion | €228.03 Million | ▼ -54.5% |
| 2015 | 0.41x | €800.01 Million | €1.94 Billion | €515.34 Million | ▲ +12.3% |
| 2014 | 0.37x | €641.36 Million | €1.75 Billion | €356.70 Million | ▲ +38.3% |
| 2013 | 0.27x | €354.40 Million | €1.34 Billion | €350.35 Million | — |